Carmela R. Abraham

13.7k citations

126 papers · 9.1k indexed · 4 hit papers · h-index 48

Physiology top 0.2%
Molecular Biology top 2%
Neurology top 0.2%
Cellular and Molecular Neuroscience top 1%
Genetics top 1%

Co-authors: Dennis J. Selkoe Huntington Potter Lennart Mucke Eliezer Masliah Ci-Di Chen D. J. Selkoe Daniel A. Kirschner Douglas L. Rosene
Topics: Alzheimer's disease research and treatments (66 papers)Parathyroid Disorders and Treatments (24 papers)Genetic Syndromes and Imprinting (22 papers)
Cited by: Neurology Nephrology Physiology
Journals: Nature Cell Proceedings of the National Academy of Sciences
Partner nations: United States United Kingdom Spain

In The Last Decade

Carmela R. Abraham

125 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.

1993 861 citations Carmela R. Abraham, Eliezer Masliah et al. Proceedings of the National Academy of Sciences profile →
Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1988 750 citations Carmela R. Abraham, Dennis J. Selkoe et al. Cell profile →
Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice

1994 574 citations Eliezer Masliah, Edward Rockenstein et al. profile →
X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation.

1986 458 citations Daniel A. Kirschner, Carmela R. Abraham et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Carmela R. Abraham

Since Specialization

Citations

This map shows the geographic impact of Carmela R. Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmela R. Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmela R. Abraham more than expected).

Fields of papers citing papers by Carmela R. Abraham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmela R. Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmela R. Abraham. The network helps show where Carmela R. Abraham may publish in the future.

Co-authorship network of co-authors of Carmela R. Abraham

This figure shows the co-authorship network connecting the top 25 collaborators of Carmela R. Abraham. A scholar is included among the top collaborators of Carmela R. Abraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmela R. Abraham. Carmela R. Abraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term effects of s-KL treatment in wild-type mice: Enhancing longevity, physical well-being, and neurological resilience 2025 ·Molecular Therapy ·(unknown),(unknown),(unknown),(unknown),Cristina Sánchez‐de‐Diego,(unknown),(unknown),Carmela R. Abraham,Assumpció Bosch,Francesc Ventura,(unknown),Pura Muñoz-Cánoves,Miguel Chillón	2
2	Knockout of the longevity gene Klotho perturbs aging and Alzheimer’s disease-linked brain microRNAs and tRNA fragments 2024 ·Communications Biology ·(unknown),Estelle R. Bennett,Nadav Yayon,(unknown),David A. Bennett,Sudha Seshadri,Elliott J. Mufson,(unknown),David Greenberg,Makoto Kuro‐o,Iddo Paldor,Carmela R. Abraham,Hermona Soreq	11
3	Activation of the Anti-Aging and Cognition-Enhancing Gene Klotho by CRISPR-dCas9 Transcriptional Effector Complex 2018 ·Journal of Molecular Neuroscience ·Ci-Di Chen,Ella Zeldich,Yuexuan Li,Andrea Yuste,Carmela R. Abraham	30
4	Klotho Is a Neuroprotective and Cognition-Enhancing Protein 2016 ·Vitamins and hormones ·Carmela R. Abraham,Patrick Mullen,(unknown),(unknown),Ella Zeldich	62
5	The Neuroprotective Effect of Klotho is Mediated via Regulation of Members of the Redox System 2014 ·Journal of Biological Chemistry ·Ella Zeldich,Ci-Di Chen,Teresa A. Colvin,Erin Bove‐Fenderson,Jennifer Liang,(unknown),David A. Harris,Carmela R. Abraham	173
6	The Anti-Aging and Tumor Suppressor Protein Klotho Enhances Differentiation of a Human Oligodendrocytic Hybrid Cell Line 2014 ·Journal of Molecular Neuroscience ·(unknown),Hu Li,Jennifer Liang,(unknown),Ella Zeldich,Carmela R. Abraham	46
7	Biochemical and Functional Characterization of the Klotho-VS Polymorphism Implicated in Aging and Disease Risk 2013 ·Journal of Biological Chemistry ·(unknown),Gwendalyn D. King,Ci-Di Chen,Carmela R. Abraham	32
8	P3‐469: Development of Klotho enhancers as novel therapeutics for Alzheimer's disease 2010 ·Alzheimer s & Dementia ·Carmela R. Abraham,Ci-Di Chen,Gwendalyn D. King	1
9	Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17 2007 ·Proceedings of the National Academy of Sciences ·Ci-Di Chen,Sonia Podvin,E Gillespie,Susan E. Leeman,Carmela R. Abraham	463
10	Age‐related molecular reorganization at the node of Ranvier 2006 ·The Journal of Comparative Neurology ·Jason D. Hinman,Alan Peters,Howard Cabral,Douglas L. Rosene,William Hollander,Matthew N. Rasband,Carmela R. Abraham	67
11	Age‐dependent myelin degeneration and proteolysis of oligodendrocyte proteins is associated with the activation of calpain‐1 in the rhesus monkey 2002 ·Journal of Neurochemistry ·Jacob A. Sloane,Jason D. Hinman,(unknown),William Hollander,Carmela R. Abraham	73
12	Astroglial Expression of Human α1-Antichymotrypsin Enhances Alzheimer-like Pathology in Amyloid Protein Precursor Transgenic Mice 2000 ·American Journal Of Pathology ·Lennart Mucke,Gui-Qiu Yu,Lisa McConlogue,Edward Rockenstein,Carmela R. Abraham,Eliezer Masliah	110
13	Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo 1997 ·Neuroscience ·Eliezer Masliah,C. Westland,Edward Rockenstein,Carmela R. Abraham,Margaret Mallory,(unknown),(unknown),Lennart Mucke	101
14	The Fibril Forming Region of the β-Amyloid Precursor Differs from That of the Amyloid A Precursor in Its Interaction with Lipids1 1996 ·Biochemical and Biophysical Research Communications ·(unknown),Richard E. Fine,Carmela R. Abraham,Jean D. Sipe	6
15	A Novel Brain Cysteine Protease Forms an SDS Stable Complex with the β‐Amyloid Precursor Proteina 1996 ·Annals of the New York Academy of Sciences ·(unknown),Carmela R. Abraham	10
16	Allele ϵ4 of Apolipoprotein E Shows a Dose Effect on Age at Onset of Pick Disease 1995 ·Experimental Neurology ·Lindsay A. Farrer,Carmela R. Abraham,L. Volicer,(unknown),Neil W. Kowall,Ann C. McKee,John M. Wells	47
17	Identification of a metalloprotease from Alzheimer's disease brain able to degrade the .beta.-amyloid precursor protein and generate amyloidogenic fragments 1994 ·Biochemistry ·(unknown),Robert Siman,Richard W. Scott,Carmela R. Abraham	41
18	A calcium-stimulated serine protease from monkey brain degrades the β-amyloid precursor protein 1992 ·Brain Research ·Bronwyn L. Razzaboni,(unknown),Edward H. Koo,Carmela R. Abraham	33
19	Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's diseasebreakdown → 1988 ·Cell ·Carmela R. Abraham,Dennis J. Selkoe,Huntington Potter	750
20	X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation.breakdown → 1986 ·Proceedings of the National Academy of Sciences ·Daniel A. Kirschner,Carmela R. Abraham,D. J. Selkoe	458

About Carmela R. Abraham

Carmela R. Abraham is a scholar working on Nephrology, Physiology and Developmental Neuroscience, having authored 126 papers that have together received 9.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (66 papers), Parathyroid Disorders and Treatments (24 papers) and Genetic Syndromes and Imprinting (22 papers). The work is most often cited by research in Neurology (1.7k citations), Nephrology (1.3k citations) and Physiology (4.1k citations). Carmela R. Abraham has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Dennis J. Selkoe, Huntington Potter, Lennart Mucke, Eliezer Masliah, Ci-Di Chen, D. J. Selkoe, Daniel A. Kirschner, Douglas L. Rosene, Edward Rockenstein and Yasuo Ihara. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact